Cargando…

Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes

Detalles Bibliográficos
Autores principales:	Zhao, Houyu, Zhuo, Lin, Sun, Yexiang, Shen, Peng, Lin, Hongbo, Zhan, Siyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2023
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345969/ https://www.ncbi.nlm.nih.gov/pubmed/37169365 http://dx.doi.org/10.1111/1753-0407.13408

Ejemplares similares

Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
por: Zhao, Houyu, et al.
Publicado: (2023)

Thiazolidinedione use and risk of Parkinson’s disease in patients with type 2 diabetes mellitus
por: Zhao, Houyu, et al.
Publicado: (2022)

Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes
por: Wasif, Uzayr, et al.
Publicado: (2023)

Sulfonylurea and Cancer Risk Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
por: Zhao, Houyu, et al.
Publicado: (2022)

The effectiveness of influenza vaccine among elderly Chinese: A regression discontinuity design based on Yinzhou regional health information platform
por: Liu, Guangxu, et al.
Publicado: (2022)

Statins use and risk of new-onset diabetes in hypertensive patients: a population-based retrospective cohort study in Yinzhou district, Ningbo city, People’s Republic of China
por: Li, Hailong, et al.
Publicado: (2018)

Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017: A Population-Based Study in the Yinzhou District, Ningbo City of China
por: Li, Hailong, et al.
Publicado: (2021)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
por: Barnett, Anthony H
Publicado: (2009)

Long-Term Patterns of Antidiabetic Medication Use in Patients with Type 2 Diabetes
por: Xu, Yang, et al.
Publicado: (2018)

Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort
por: Liu, Zhike, et al.
Publicado: (2022)

Response to Commentaries on Sakaluk (2020)
por: Sakaluk, John K.
Publicado: (2021)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Barotrauma in critically ill patients with COVID-19: the more we learn, the less we know! Response to the commentary
por: Venkateswaran, Vineeta, et al.
Publicado: (2023)

Response to Commentary: Treating Alzheimer Dementia With CT-Induced Low-Dose Ionizing Radiation: Problematic, Yet Potential for More Precise Inquiry
por: Cuttler, Jerry M.
Publicado: (2017)

Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?
por: Nasri, Hamid
Publicado: (2013)

More than a “Commentary”: response to Cassivi and Blanchet Garneau’s “More than juxtaposition” commentary
por: Willis, Henry A., et al.
Publicado: (2023)

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes
por: Stafford, John M, et al.
Publicado: (2007)

Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
por: Bae, Jaehyun, et al.
Publicado: (2021)

Commentary: Barotrauma in critically ill patients with COVID-19: miles to go to unwrap the pathophysiology
por: Bhattacharya, Dipasri, et al.
Publicado: (2023)

Commentary on: Effects of Cinnamon Consumption on Glycemic Status, Lipid Profile and Body Composition in Type 2 Diabetic Patients
por: Nasri, Hamid, et al.
Publicado: (2013)

Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Response to “Commentary on: Total Composite Flap Facelift and the Deep-Plane Transition Zone: A Critical Consideration in SMAS-Release Midface Lifting”
por: Mani, Marc
Publicado: (2016)

Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
por: Lin, Chu, et al.
Publicado: (2023)

Commentary
por: Wildenauer, René
Publicado: (2013)

Commentary
por: Emami, Mehrdad
Publicado: (2015)

Commentary
por: Curtò, Lorenzo
Publicado: (2015)

Commentary
por: Menon, Girish
Publicado: (2017)

Commentary
por: Mohammed, Wail
Publicado: (2019)

Commentary
por: Satyarthee, Guru Dutta
Publicado: (2019)

Commentary
por: Das, Dilip Kumar
Publicado: (2019)

Commentary
por: Chaturvedi, Sujata
Publicado: (2019)

Microangiopathy in snake bites—bubble trouble: Response to commentary
por: Enjeti, Anoop K., et al.
Publicado: (2019)

Internet addiction among young Bangladeshi adults: critical commentary on Hassan et al. (2020)
por: Griffiths, Mark D., et al.
Publicado: (2020)

Critical Comment on Depression in Main Caregivers of Dementia Patients: Prevalence and Predictors
por: Saini, Radha, et al.
Publicado: (2018)

Response to: Comment on “Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia”
por: Bulut, Mehmet, et al.
Publicado: (2016)

Response to: Comment on “Choroidal Thickness in Patients with Mild Cognitive Impairment and Alzheimer's Type Dementia”
por: Bulut, Mehmet, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7c4gj1ll7fphll6pa94cnos5ti